Cost-Utility Analysis of Mycophenolate Mofetil versus Methotrexate for Noninfectious Uveitis
Abstract
A cost-utility analysis of methotrexate (MTX) versus mycophenolate mofetil (MMF) for noninfectious intermediate, posterior, and panuveitis using data from the FAST Uveitis Trial showed MTX to have a lower cost/QALY, but both are...
Paper Details
Title
Cost-Utility Analysis of Mycophenolate Mofetil versus Methotrexate for Noninfectious Uveitis
Published Date
Dec 1, 2021
Journal
Volume
5
Issue
12
Pages
1281 - 1282
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History